Oxyphenbutazone Anhydrous

Oxyphenbutazone Anhydrous

SCHEMBL5612853

CCCCC1C(=O)N(c2ccccc2)N(c2ccc(O)cc2)C1=O.OCCO

nearest known ligand 0.92

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

PTGS1PTGS2

The experimentally established mechanism targets of Oxyphenbutazone Anhydrous. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 known ✓ P23219 2/20 0.92
LMNA P02545 3/20 0.92
RAB9A P51151 3/20 0.92
ALDH1A1 P00352 2/20 0.92
CYP3A4 P08684 2/20 0.92
MAPK1 P28482 2/20 0.92
CYP1A2 P05177 2/20 0.92
CYP2C9 P11712 2/20 0.92
CYP2C19 P33261 2/20 0.92
TP53 P04637 1/20 0.92
MAPT P10636 1/20 0.92
HPGD P15428 1/20 0.92
NAPRT Q6XQN6 1/20 0.92
ABCB11 O95342 1/20 0.46
KDM4E B2RXH2 2/20 0.44
PKM P14618 1/20 0.44
GRM2 Q14416 6/20 0.39
GAA P10253 2/20 0.38
NPC1 O15118 1/20 0.38
MEN1 O00255 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxyphenbutazone Anhydrous SCHEMBL5316370 0.96 LMNA (1.00) LMNARAB9AALDH1A1CYP3A4PTGS1
Oxyphenbutazone Anhydrous SCHEMBL25857 0.96 LMNA (1.00) LMNARAB9AALDH1A1CYP3A4PTGS1
Oxyphenbutazone Anhydrous SCHEMBL11337449 0.96 LMNA (1.00) LMNARAB9AALDH1A1CYP3A4PTGS1
Oxyphenbutazone Anhydrous SCHEMBL25856 0.96 LMNA (1.00) LMNARAB9AALDH1A1CYP3A4PTGS1
Oxyphenbutazone Anhydrous SCHEMBL1263248 0.94 LMNA (0.97) LMNARAB9AALDH1A1CYP3A4PTGS1
Oxyphenbutazone Anhydrous SCHEMBL2525061 0.94 LMNA (0.97) LMNARAB9AALDH1A1CYP3A4PTGS1
Oxyphenbutazone Anhydrous SCHEMBL25854 0.94 LMNA (0.97) LMNARAB9AALDH1A1CYP3A4PTGS1
Oxyphenbutazone Anhydrous SCHEMBL3182776 0.94 LMNA (0.97) LMNARAB9AALDH1A1CYP3A4PTGS1
Oxyphenbutazone Anhydrous SCHEMBL1263243 0.93 LMNA (0.94) LMNARAB9AALDH1A1CYP3A4PTGS1
Oxyphenbutazone Anhydrous SCHEMBL28278628 0.93 LMNA (0.94) LMNARAB9AALDH1A1CYP3A4PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1200040-B8 TWO-COMPONENT COMPOSITION FOR COSMETIC OR PHARMACEUTICAL USE IND E COM DE COSMETICOS NATURA (BR) 2006-09-13 EP claimed
EP-1200040-A1 TWO-COMPONENT COMPOSITION FOR COSMETIC OR PHARMACEUTICAL USE Industria e Comercio de Comesticos Natura Ltda (BR) 2002-05-02 EP claimed
WO-2001005357-A1 TWO-COMPONENT COMPOSITION FOR COSMETIC OR PHARMACEUTICAL USE Indústria e Comércio de Cosméticos Natura Ltda. (BR) 2001-01-25 WO claimed
EP-2666517-B1 Anticaries formulation QUATTROTI DENTECH S R L (IT) 2016-07-13 EP disclosed
EP-2666517-A1 Anticaries formulation Brux S.R.L. (IT) 2013-11-27 EP disclosed
EP-1491566-B1 Curable epoxy resin composition, and process for the production of shaped articles therefrom ABB TECHNOLOGY LTD (CH) 2007-02-28 EP disclosed
EP-1200040-B8 TWO-COMPONENT COMPOSITION FOR COSMETIC OR PHARMACEUTICAL USE IND E COM DE COSMETICOS NATURA (BR) 2006-09-13 EP disclosed
US-20050004270-A1 Curable epoxy resin composition, fabrication process using the same and shaped articles obtained therefrom ABB T & D TECHNOLOGY LTD. (CH) 2005-01-06 US disclosed
EP-1200040-A1 TWO-COMPONENT COMPOSITION FOR COSMETIC OR PHARMACEUTICAL USE Industria e Comercio de Comesticos Natura Ltda (BR) 2002-05-02 EP disclosed
WO-2001005357-A1 TWO-COMPONENT COMPOSITION FOR COSMETIC OR PHARMACEUTICAL USE Indústria e Comércio de Cosméticos Natura Ltda. (BR) 2001-01-25 WO disclosed